
Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose for Covishield, Covaxin
India Today
Biological E has sought permission from DCGI to conduct the phase-3 clinical trial for its Covid-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its Covid-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Currently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in adults aged 18 years to 80 years, is underway and the results are likely to be declared this month.

Lalu Prasad Yadav's elder son, Tej Pratap, is speaking of wisdom and devotion again. He's no longer the Krishna bhakt that he was. He is now sporting saffron attire in Reels, and is propagating Shiva bhakti. His new Instagram handle is SantTejPratapYadav. After political and personal isolation, Teju bhaiya seems to have found solace in Rudraksha, Shiva bhajans and the Shiva Puran.












